Body Composition and Acute Stroke
ConditionAcute Stroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Régional d'Orléans
About this trial
Body composition appears to be a prognostic factor for the severity and functional outcome of stroke patients. In this study the prognostic value of two bioimpedance parameters will be studied (skeletal mass index and phase angle) and two temporal muscle measurements (thickness and surface area) to predict the functional outcome of patients at discharge and at 6 months
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
volunteer stroke patients in acute phase
Age ≥ 18 years
Having had a brain MRI
Able to understand assessment guidelines
Disqualifiers
Person under tutorship or curatorship
Person under court protection
Persons deprived of their liberty
Pregnant or breastfeeding women
Trial design
Design model
Single group
Treatments tested in this trial
Modified Rankin scale
Diagnostic testAcute stroke patients will undergo modified rankin scale
Treatment groups
250 Participants
are divided into 1 treatment groupGroup A: Acute stroke patientsOther 1 intervention
Trial outcomes
Primary outcomes
1
phase angle
Time frame
72 hours after stroke2
thickness of temporal muscle
Time frame
72 hours after stroke3
surface area of temporal muscle
Time frame
72 hours after strokeSecondary outcomes
1
Modified Rankin Scale (mRS)
The modified Rankin Scale is used to assess the disability of patients in the acute phase of stroke recovery. It consists of a single item, with 5 levels corresponding to no disability, mild disability, moderate disability, moderately severe disability and severe disability.
Time frame
Month 62
Modified Rankin Scale (mRS)
The modified Rankin Scale is used to assess the disability of patients in the acute phase of stroke recovery. It consists of a single item, with 5 levels corresponding to no disability, mild disability, moderate disability, moderately severe disability and severe disability.
Time frame
Through month 33
skeletal muscular Index
Time frame
72 hours after strokeSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov